References
- Tsujimoto Y, Finger L R, Yunis J, Nowell P C, Croce C M. Cloning of the chromosome breakpoint of the neoplastic B cells with the t(14;18) chromosome translocation. Science 1984; 226: 1097–9
- Villuendas R, Piris M A, Orradre J L, Mollejo M, Rodriquez R, Morente M. Different bcl-2 protein expression in high-grade B-cell lymphomas derived from lymph node of mucosa-associated lymphoid tissue. Am J Pathol 1991; 139: 989–93
- Hockenbery D M, Zutter M, Hickey W, Nahm M, Korsmeyer J. BCL2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 1991; 88: 6961–5
- Tanaka S, Louie D C, Kant J A, Reed J C. Frequent incidence of somatic mutations in translocated BCL2 oncogenes of non-Hodgin's lymphomas. Blood 1992; 79: 229–37
- Pezzella F, Jones M, Ralfkiaer E, Ersboll J, Gatter K C, Mason D Y. Evaluation of bcl-2 protein expression and 14;18 translocation as prognostic markers in follicular lymphoma. Br J Cancer 1992; 65: 87–9
- Cuende E, Alés-Martínez J E, Ding L, Gónzalez-Garcia M, Martínez AC, Nunez G. Programmed cell death by bcl-2-dependent and independent mechanisms in B lymphoma cells. EMBO J 1993; 12: 1555–60
- Raffo A J, Perlman H, Chen M W, Day M L, Streitman J S, Buttyan R. Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo. Cancer Res 1995; 55: 4438–45
- Eliopoulos A G, Kerr D J, Herod J, Hodgkins L, Kra-Jewski S, Reed J C, Young L S. The control of apoptosis and drug resistance in ovarian cancer: influence of p53 and Bcl-2. Oncogene 1995; 11: 1217–28
- Leek R D, Kaklamanis L, Pezzella F, Gatter K C, Harris A L. bcl-2 in normal human breast and carcinoma, association with oestrogen receptor-positive, epidermal growth factor receptor-negative tumours and in situ cancer. Br J Cancer 1994; 69: 135–9
- Dole M, Nuñez G, Merchant J, Rode C K, Bloch C A, Castle V P. Bcl-2 inhibits chemotherapy-induced apoptosis in neuroblastoma. Cancer Res 1994; 54: 3253–9
- Bissonnette R P, Echeverri F, Mahboubi A, Green D R. Apoptotic cell death induced by c-myc is inhibited by bcl-2. Nature 1992; 359: 552–4
- Yin D X, Schimke R T. BCL-2 expression delays drug-induced apoptosis but does not increase clonogenic survival after drug treatment in HeLa cells. Cancer Res 1995; 55: 4922–8
- Strasser A, Harris A W, Cory S. bcl-2 transgene inhibits T cell death and perturbs thymic self-censorship. Cell 1991; 67: 889–99
- Tsujimoto Y, Croce C M. Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc Natl Acad Sci USA 1986; 83: 5214–8
- Lithgow T, van Driel R, Bertram J F, Strasser A. The protein product of the oncogene bcl-2 is a component of the nuclear envelope, the endoplasmic reticulum, and the outer mitochondrial membrane. Cell Growth Differ 1994; 5: 411–7
- Lu Q L, Hanby A M, Hajibagheri M AN, et al. Bcl-2 protein localizes to chromosomes of mitotic nuclei and is correlated with the cell cycle in cultured epithelial cell lines. J Cell Sci 1994; 107: 363–71
- Cann C I, Fried M P, Rothman K J. Epidemiology of squamous cell cancer of the head and neck. Otolaryngol Clin 1985; 18: 1–22
- Grénman R, Burk D, Virolainen E, Wagner J G, Lichter A S, Carey T E. Radiosensitivity of head and neck cancer cells in vitro—a 96-well plate clonogenic cell assay for squamous cell carcinoma. Arch Otolaryngol Head Neck Surg 1988; 114: 427–31
- Servomaa K, Kiuru A, Grénman R, Pekkola-Heino K, Pulkkinen J O, Rytömaa T. p53 mutations associated with increased sensitivity to ionizing radiation in human head and neck cancer cell lines. Cell Prolif 1996; 29: 219–30
- Pekkola-Heino K, Servomaa K, Kiuru A, Grénman R. Increased radiosensitivity is associated with p53 mutations in cell lines derived from oral cavity carcinoma. Acta Otolaryngol (Stockh) 1996; 116: 341–4
- Pekkola-Heino K M. Radiation response of squamous cell carcinoma—in vitro studies with cell lines in 96-well plate clonogenic assay. Turku 1992; 56
- Ah-See K W, Cooke T G, Pickford I R, Soutar D, Balmain A. An allelotype of squamous carcinoma of the head and neck using microsatellite markers. Cancer Res 1994; 54: 1617–21
- Weber J L, May P E. Dinucleotide repeat polymorphism at the D18S34 locus. Nucleic Acids Res 1990; 18: 2201